Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Apr 2001

Chitolie A, Lawrie A S, Mackie I J, Harrison P, Machin S J

Abstract excerpt

Several methods are now available for the laboratory assessment of activated protein C resistance (APCR). In this study, we evaluated two activated partial thromboplastin time-based assays [Coatest activated protein C (APC) and Diagen protein C activator (PCA)], with and without predilution of test plasma in factor V-deficient plasma (FVdp) and an amidolytic assay (Immuno Ltd, Vienna, Austria). Testing plasmas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activated Protein C Resistance
Share to Deamino Arginine Vasopressin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Endpoint Determination

Share to Factor V Deficiency

Share to False Negative Reactions

Share to Lupus Coagulation Inhibitor

Share to Partial Thromboplastin Time

Share to Protein S

Source

Identifiers

PMID: 11414631
DOI: 10.1097/00001721-200104000-00003

Genes

APC
OAT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance.PMID 11414631Read ↗

Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.Semantic proximity Read ↗

Proposal for objective evaluation of the performance of various functional APC-resistance tests in genotyped patients.Semantic proximity Read ↗

Determination of activated protein C resistance in anticoagulated and lupus positive patients.Semantic proximity Read ↗

Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.Semantic proximity Read ↗

Comparison of three activated protein C resistance tests in the risk assessment of venous thrombosis in non-carriers of the factor V Leiden mutation.Semantic proximity Read ↗

Limitations of a calibrated, quantitative APC-R assay under routine conditions.Semantic proximity Read ↗

The use of two different APC resistance assay systems provides optimal sensitivity and specificity for diagnosing genetic APC resistance.Semantic proximity Read ↗

A comparison between two activated protein C resistance methods as routine diagnostic tests for factor V Leiden mutation.Semantic proximity Read ↗

Screening for the FV:Q506 mutation--evaluation of thirteen plasma-based methods for their diagnostic efficacy in comparison with DNA analysis.Semantic proximity Read ↗

Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant.Semantic proximity Read ↗

Activated Factor X-Based versus Thrombin-Based Antithrombin Testing in Thrombophilia Workup in the DOAC Era.Semantic proximity Read ↗

Whole blood screening test for factor V Leiden using a Russell viper venom time-based assay.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.